Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis

References

• Jemal A, Bary F, Center MM, Ferley J, Ward E, et al.: Global cancer statistics. CA Cancer J Clin 61, 69–90, 2011.
   PubMed Web of Science ®Google Scholar
• American Cancer Society: Breast Cancer Facts and Figures 2011–2012. Atlanta: American Cancer Society, Inc., 2011.
   Google Scholar
• Siegel R, Ma J, Zou Z, and Jemal A: Cancer statistics, 2014. CA Cancer J Clin 64, 9–29, 2014.
   PubMed Web of Science ®Google Scholar
• Yabroff KR, Lund J, Kepka D, and Mariotto A: Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev 20, 2006–2014, 2011.
   PubMed Web of Science ®Google Scholar
• Campeau PM, Foulkes WD, and Tischkowitz MD: Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 124, 31–42, 2008.
   PubMed Web of Science ®Google Scholar
• Alberg AJ and Helzlsouer KJ: Epidemiology, prevention, and early detection of breast cancer. Curr Opin Oncol 9, 505–511, 1997.
   PubMedGoogle Scholar
• Hanf V and Hanf D: Reproduction and breast cancer risk. Breast Care 9, 398–405, 2014.
   PubMed Web of Science ®Google Scholar
• Singletary KW and Gapstur SM: Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. JAMA 286, 2143–2151, 2001.
   PubMed Web of Science ®Google Scholar
• Crujeiras AB, Díaz-Lagares A, Carreira MC, Amil M, and Casanueva FF: Oxidative stress associated to dysfunctional adipose tissue: a potential link between obesity, type 2 diabetes mellitus and breast cancer. Free Radic Res 47, 243–256, 2013.
   PubMed Web of Science ®Google Scholar
• Pierobon M and Frankenfeld CL: Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis. Breast Cancer Res Treat 137, 307–314, 2013.
   PubMed Web of Science ®Google Scholar
• Cuzick J, DeCensi A, Arun B, Brown PH, Castiglione M, et al.: Preventive therapy for breast cancer: a consensus statement. Lancet Oncol 12, 496–503, 2011.
   PubMed Web of Science ®Google Scholar
• Nelson HD, Smith ME, Griffin JC, and Fu R: Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. preventive services task force. Ann Intern Med 158, 604–614, 2013.
   PubMed Web of Science ®Google Scholar
• Lazzeroni M and DeCensi A: Breast cancer prevention by antihormones and other drugs: where do we stand? Hematol Oncol Clin North Am 27, 657–672, 2013.
   PubMed Web of Science ®Google Scholar
• Steward WP and Brown K: Cancer chemoprevention: a rapidly evolving field. Br J Cancer 109, 1–7, 2013.
   PubMed Web of Science ®Google Scholar
• Ogunleye AA, Xue F, and Michels KB: Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 119, 477–484, 2010.
   PubMed Web of Science ®Google Scholar
• Song JK and Bae JM: Citrus fruit intake and breast cancer risk: a quantitative systematic review. J Breast Cancer 16, 72–76, 2013.
   PubMed Web of Science ®Google Scholar
• Chajès V and Romieu I: Nutrition and breast cancer. Maturitas 77, 7–11, 2014.
   PubMed Web of Science ®Google Scholar
• Kado K, Forsyth A, Patel PR, and Schwartz JA: Dietary supplements and natural products in breast cancer trials. Front Biosci 4, 546–567, 2012.
   Google Scholar
• Bishayee A, Ahmed S, Brankov N, and Perloff M: Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer. Front. Biosci 16, 980–996, 2011.
   PubMed Web of Science ®Google Scholar
• Reuben SC, Gopalan A, Petit DM, and Bishayee A: Modulation of angiogenesis by dietary phytoconstituents in the prevention and intervention of breast cancer. Mol Nutr Food Res 56, 14–29, 2012.
   PubMed Web of Science ®Google Scholar
• Vadodkar AS, Suman S, Lakshmanaswamy R, and Damodaran C: Chemoprevention of breast cancer by dietary compounds. Anticancer Agents Med Chem 12, 1185–1202, 2012.
   PubMed Web of Science ®Google Scholar
• Ismail T, Sestili P, and Akhtar S: Pomegranate peel and fruit extracts: a review of potential anti-inflammatory and anti-infective effects. J Ethnopharmacol 143, 397–405, 2012.
   PubMed Web of Science ®Google Scholar
• Jurenka JS: Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev 13, 128–144, 2008.
   PubMed Web of Science ®Google Scholar
• Faria A and Calhau C: The bioactivity of pomegranate: impact on health and disease. Crit Rev Food Sci Nutr 51, 626–634, 2011.
   PubMed Web of Science ®Google Scholar
• Johanningsmeier SD and Harris GK: Pomegranate as a functional food and nutraceutical source. Annu Rev Food Sci Technol 2, 181–201, 2011.
   PubMed Web of Science ®Google Scholar
• Viladomiu M, Hontecillas R, Lu P, and Bassaganya-Riera J: Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents. Evid Based Complement Alternat Med 2013, 789764, 2013.
   PubMed Web of Science ®Google Scholar
• Heber D: Pomegranate ellagitannins. In: Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed., Benzie IFF, Wachtel-Galor S, eds. Boca Raton: CRC Press; 2011, pp. 201–210.
   Google Scholar
• Lansky EP and Newman RA: Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. J Ethnopharmacol 109, 177–206, 2007.
   PubMed Web of Science ®Google Scholar
• Adhami VM, Khan N, and Mukhtar H. Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer 6, 811–815, 2009.
   Web of Science ®Google Scholar
• Kim ND, Mehta R, Yu W, Neeman I, Livney T, et al.: Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71, 203–217, 2002.
   PubMed Web of Science ®Google Scholar
• Adams LS, Zhang Y, Seeram NP, Heber D, and Chen S: Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res 3, 108–113, 2010.
   PubMed Web of Science ®Google Scholar
• Dikmen M, Ozturk N, and Ozturk Y: The antioxidant potency of Punica granatum L. fruit peel reduces cell proliferation and induces apoptosis on breast cancer. J Med Food 14, 1638–1646, 2011.
   PubMed Web of Science ®Google Scholar
• Joseph MM, Aravind SR, Varghese S, Mini S, and Sreelekha TT: Evaluation of antioxidant, antitumor and immunomodulatory properties of polysaccharide isolated from fruit rind of Punica granatum. Mol Med Rep 5, 489–496, 2012.
   PubMed Web of Science ®Google Scholar
• Banerjee N, Talcott S, Safe S, and Mertens-Talcott SU: Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res Treat 136, 21–34, 2012.
   PubMed Web of Science ®Google Scholar
• Shirode AB, Kovvuru P, Chittur SV, Henning SM, Heber D, et al.: Antiproliferative effects of pomegranate extract in MCF-7 breast cancer cells are associated with reduced DNA repair gene expression and induction of double strand breaks. Mol Carcinog 53, 458–470, 2014.
   PubMed Web of Science ®Google Scholar
• Mehta R and Lansk EP: Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev 13, 345–348, 2004.
   PubMed Web of Science ®Google Scholar
• Dai Z, Nair V, Khan M, and Ciolino HP: Pomegranate extract inhibits the proliferation and viability of MMTV-Wnt-1 mouse mammary cancer stem cells in vitro. Oncol Rep 24, 1087–1091, 2010.
   PubMed Web of Science ®Google Scholar
• Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, et al.: Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr Cancer Ther 8, 242–253, 2009.
   PubMed Web of Science ®Google Scholar
• Rocha A, Wang L, Penichet M, and Martins-Green M: Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer. Breast Cancer Res Treat 136, 647–658, 2012.
   PubMed Web of Science ®Google Scholar
• Bishayee A, Bhatia D, Thoppil RJ, Darvesh AS, Nevo E, et al.: Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 32, 888–896, 2011.
   PubMed Web of Science ®Google Scholar
• Bishayee A, Mandal A, Thoppil RJ, Darvesh AS, and Bhatia D: Chemopreventive effect of a novel oleanane triterpenoid in a chemically induced rodent model of breast cancer. Int J Cancer 133, 1054–1064, 2013.
   PubMed Web of Science ®Google Scholar
• Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SR, et al.: Comparative study of human and rat mammary tumorigenesis. Lab Invest 62, 244–278, 1990.
   PubMed Web of Science ®Google Scholar
• Russo J and Russo IH: Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia 5, 187–200, 2000.
   PubMed Web of Science ®Google Scholar
• Bishayee A and Dhir N: Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis. Chem Biol Interact 179, 131–144, 2009.
   PubMed Web of Science ®Google Scholar
• Floros KV, Thomadaki H, Florou D, Talieri M, and Scorilas A: Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide. Ann N Y Acad Sci 1090, 89–97, 2006.
   PubMed Web of Science ®Google Scholar
• Bishayee A, Thoppil RJ, Darvesh AS, Ohanyan V, Meszaros JG, et al.: Pomegranate phytoconstituents blunt the inflammatory cascade in a chemically induced rodent model of hepatocellular carcinogenesis. J Nutr Biochem 24, 178–187, 2013.
   PubMed Web of Science ®Google Scholar
• Bhatia D, Thoppil RJ, Mandal A, Samtani KA, Darvesh AS, et al.: Pomegranate bioactive constituents suppress cell proliferation and induce apoptosis in an experimental model of hepatocellular carcinoma: role of Wnt/ β-catenin signaling pathway. Evid Based Complement Alternat Med 2013, 371813, 2013.
   PubMed Web of Science ®Google Scholar
• Patel C, Dadhaniya P, Hingorani L, and Soni MG: Safety assessment of pomegranate fruit extract: acute and subchronic toxicity studies. Food Chem Toxicol 46, 2728–2735, 2008.
   PubMed Web of Science ®Google Scholar
• Christov K, Grubbs C, Shikaitis A, Juliana MM, and Lubet RA: Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer model. Clin Cancer Res 13, 5488–5496, 2007.
   PubMed Web of Science ®Google Scholar
• Al-Dhaheri WS, Hassouna I, Al-Salam S, and Karam SM: Characterization of breast cancer progression in the rat. Ann NY Acad Sci 1138, 121–131, 2008.
   PubMed Web of Science ®Google Scholar
• Jeune MA, Kumi-Diaka J, and Brown J: Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food 8, 469–475, 2005.
   PubMed Web of Science ®Google Scholar
• Chen N and Wang J: Initiator caspases in apoptosis signaling pathways. Apoptosis 7, 313–319, 2002.
   PubMed Web of Science ®Google Scholar
• Krajewski S, Krajewska M, Turner BC, Pratt C, Howard B, et al.: Prognostic significance of apoptosis regulators in breast cancer. Endocr Relat Cancer 6, 29–40, 1999.
   PubMed Web of Science ®Google Scholar
• Lansky EP, Jiang W, Mo H, Bravo L, Froom P, et al.: Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs 23, 11–20, 2005.
   PubMed Web of Science ®Google Scholar
• Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, et al.: In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16, 360–367, 2005.
   PubMed Web of Science ®Google Scholar